Connection
Robert Dellavalle to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Robert Dellavalle has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
|
|
Connection Strength |
|
|
|
|
|
1.643 |
|
|
|
-
Meckley AL, Militello M, Sivesind TE, Schilling L, Dellavalle RP. From the Cochrane Library: Statins and Fibrates for Preventing Melanoma. Dermatology. 2022; 238(4):668-669.
Score: 0.609
-
Mounessa J, Buntinx-Krieg T, Qin R, Dunnick CA, Dellavalle RP. Primary and Secondary Chemoprevention of Malignant Melanoma. Am J Clin Dermatol. 2016 Dec; 17(6):625-634.
Score: 0.430
-
Freeman SR, Drake AL, Heilig LF, Graber M, McNealy K, Schilling LM, Dellavalle RP. Statins, fibrates, and melanoma risk: a systematic review and meta-analysis. J Natl Cancer Inst. 2006 Nov 01; 98(21):1538-46.
Score: 0.214
-
Dellavalle RP, Drake A, Graber M, Heilig LF, Hester EJ, Johnson KR, McNealy K, Schilling L. Statins and fibrates for preventing melanoma. Cochrane Database Syst Rev. 2005 Oct 19; (4):CD003697.
Score: 0.199
-
Shellman YG, Ribble D, Miller L, Gendall J, Vanbuskirk K, Kelly D, Norris DA, Dellavalle RP. Lovastatin-induced apoptosis in human melanoma cell lines. Melanoma Res. 2005 Apr; 15(2):83-9.
Score: 0.192
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|